Onyx Healthcare, Inc.

Onyx Healthcare, Inc.

TTPEX:6569
73.60
TWD
0.00
(0.00%)
4.23EPS
21.73P/E
3.95BMarket Cap
Onyx Healthcare, Inc.
TPEX:6569
(Taipei Exchange)

Recent

price

73.60

P/E

ratio

21.73

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
23.46
25.22
33.26
31.58
36.31
39.91
41.54
37.74
34.58
42.27
38.45
31.79
33.29
36.01
Revenue per Share
1.57
2.72
4.24
4.59
3.25
5.46
6.71
4.68
3.67
5.36
6.57
4.63
2.84
4.24
Basic EPS, GAAP
-0.24
1.25
4.31
5.42
2.86
4.22
10.3
4.88
-8.02
3.88
7.28
3.01
3.74
-1.3
Free Cash Flow per Basic Share
0.09
0.19
1.39
2.41
3.57
3.64
3.64
3.7
4.35
3.51
4.28
4.29
3.92
- -
Dividend per Share
5.56
8.39
10.24
24.82
24.38
25.43
28.23
29.21
28.74
35.95
38.75
39.5
39.7
44.41
Book Value per Share
5.56
8.39
10.24
24.8
24.34
25.41
28.22
29.07
28.61
35.81
38.66
39.46
39.69
44.41
Tangible Book Value per Share
28
31
28
36
36
36
36
36
35
38
39
39
39
40
Basic Weighted Avg Shares
660
781
937
1,127
1,296
1,425
1,483
1,347
1,202
1,600
1,493
1,241
1,313
1,434
Sales/Revenue/Turnover
7.96
11.98
15.23
18.66
12.36
12.78
16.73
12.11
6.28
9
14.59
7.29
3.83
3.63
Operating Margin (%)
8
11
11
12
11
13
28
30
27
27
24
21
22
23
Depreciation Expense
44
84
119
164
116
195
239
167
128
203
255
181
112
169
Net Income, GAAP
19.63
18.74
21.03
18.24
18.99
16.02
18.76
18.61
9.71
16.07
16.34
12.73
8.37
8.96
Effective Tax Rate (%)
6.71
10.8
12.74
14.55
8.94
13.68
16.14
12.4
10.61
12.68
17.1
14.58
8.54
11.78
Profit Margin (%)
154
240
324
893
833
903
488
484
267
620
566
486
450
633
Working Capital
- -
- -
- -
- -
- -
- -
7
5
189
176
166
157
146
135
LT Debt
157
236
317
886
870
924
1,020
1,053
1,035
1,401
1,521
1,553
1,570
1,902
Total Equity
- -
36.79
38.25
27.53
14.48
16.62
18.98
11.99
5.43
8.11
10.7
4.32
2.6
- -
Return on Invested Capital (%)
- -
42.78
43.12
27.25
13.19
22.12
24.87
16.14
10.86
13.98
15.57
10.51
6.37
- -
Return on Capital (%)
- -
42.94
43.11
27.26
13.2
21.92
24.99
16.29
12.33
16.79
17.58
11.84
7.2
- -
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
168
248
18
LT Borrowings
110
108
105
LT Finance Leases
33
32
30
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
40
39
43
Market Capitalization
3,653
4,141
3,948

Working Capital

TWD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
882
982
915
Cash, Cash Equivalents & STI
246
268
271
Accounts Receivable, Net
224
197
146
Inventories
368
413
456
Total Current Liabilities
480
611
282
Payables & Accruals
- -
- -
- -
ST Debt
168
248
18
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.27%
9.09%
1.12%
Free Cash Flow
-20.16%
-70.58%
25.6%
Net Income, GAAP
6.3%
-1.18%
-38.02%
Sales/Revenue/Turnover
4.48%
0.92%
5.8%
Total Cash Common Dividend
- -
4.1%
-7.79%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
275
299
284
383
1,241
2025
310
357
- -
316
1,313
2026
377
429
312
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.3
0.99
0.68
1.66
4.63
2025
0.19
0.62
- -
1.18
2.84
2026
1.02
1.61
0.47
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4.29
2025
- -
- -
- -
- -
3.92
2026
- -
- -
- -
- -
- -
Business
Onyx Healthcare Inc. (6569.TWO) designs, manufactures and sells medical-grade computers and peripherals for hospital and clinical IT applications. The company offers AI-ready medical PCs and tablets; medical cart computers including the Venus series; medical panel PCs such as Mini Venus, SMA slim models and powerful MATE and MATE2 series; power banks under the UPower brand; battery management systems like ORION; mobile medical tablets in the MD series; medical PCs and monitors for digital operating rooms under the ACCEL brand; medical displays and box PCs for medical devices including MedDP and MedPC; motherboards; and industrial PCs and tablets, along with ODM/OEM services. Onyx Healthcare operates in Taiwan, the United States, Europe and internationally, targeting hospitals, clinics and telemedicine providers. Founded in 2010 and headquartered in New Taipei City, Taiwan, the company is a subsidiary of the ASUS Group with U.S. and Dutch subsidiaries. Recent developments include partnerships with NVIDIA to advance AI-powered smart healthcare and medical edge AI platforms in 2025; collaborations with Qualcomm and Intel for medical AI innovations; launches of products such as the ACCEL-A2203 Medical AI All-in-One PC, OPM-P08T medical-grade battery, Venus-224/244 Plus with Intel Arrow Lake, MD102N 10-inch tablet and SMA-1533/1833 slim panel PCs; and awards including double honors at APEA, the 9th National Industrial Innovation Award and multiple Taiwan Excellence Awards in 2024-2025.